GT Biopharma, Inc. (GTBP)
0.4949
-0.04
(-8.16%)
USD |
NASDAQ |
Feb 09, 16:00
0.4856
-0.01
(-1.88%)
After-Hours: 20:00
GT Biopharma Total Return Level : 0.5389 for Feb. 6, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| SELLAS Life Sciences Group, Inc. | 3.73 |
| Lyell Immunopharma, Inc. | 22.71 |
| Geron Corp. | 1.53 |
| Regeneron Pharmaceuticals, Inc. | 789.78 |
| Crinetics Pharmaceuticals, Inc. | 45.28 |